BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27480956)

  • 1. A Rapid and Optimized LC-MS/MS Method for the Simultaneous Extraction and Determination of Sofosbuvir and Ledipasvir in Human Plasma.
    Elkady EF; Aboelwafa AA
    J AOAC Int; 2016 Sep; 99(5):1252-9. PubMed ID: 27480956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid bioanalytical LC-MS/MS method for the simultaneous determination of sofosbuvir and velpatasvir in human plasma-application to a pharmacokinetic study in Egyptian volunteers.
    Elkady EF; Aboelwafa AA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():116-124. PubMed ID: 30384188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Pan C; Chen Y; Chen W; Zhou G; Jin L; Zheng Y; Lin W; Pan Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():255-259. PubMed ID: 26684720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of sofosbuvir and ledipasvir in human plasma by UPLC-MS/MS method: Application to fasting and fed bioequivalence studies.
    Rezk MR; Bendas ER; Basalious EB; Karim IA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():63-70. PubMed ID: 27322631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    J Pharm Biomed Anal; 2017 Sep; 143():305-310. PubMed ID: 28645021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma.
    El-Gizawy SM; El-Shaboury SR; Atia NN; Abo-Zeid MN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():432-439. PubMed ID: 29945107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sensitive UHPLC-DAD method for simultaneous determination of sofosbuvir and ledipasvir in human serum.
    Majnooni MB; Miraghaee SS; Keshavarzi S; Mohammadi B; Sajadimajd S; Hatami R; Bahrami G
    J Pharm Biomed Anal; 2021 Feb; 195():113860. PubMed ID: 33387837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS-MS simultaneous determination of atorvastatin and ezetimibe in human plasma.
    El-Bagary RI; Elkady EF; El-Sherif ZA; Kadry AM
    J Chromatogr Sci; 2014 Sep; 52(8):773-80. PubMed ID: 23885041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quick and Sensitive UPLC-ESI-MS/MS Method for Simultaneous Estimation of Sofosbuvir and Its Metabolite in Human Plasma.
    Semreen MH; Alniss HY; Mousa MK; Aboul-Enein HY
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.
    Ferrari D; Bagaglio S; Raso M; Galli L; Premaschi S; Messina E; Morsica G; Locatelli M; Uberti-Foppa C; Hasson H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():1-7. PubMed ID: 31055190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
    Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations.
    Saraya RE; Elhenawee M; Saleh H
    J Sep Sci; 2018 Sep; 41(18):3553-3560. PubMed ID: 30048040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.
    Rezk MR; Basalious EB; Amin ME
    Biomed Chromatogr; 2016 Sep; 30(9):1354-62. PubMed ID: 26821881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS method: Application to a bioequivalence study.
    Rezk MR; Basalious EB; Badr KA
    Biomed Chromatogr; 2018 Nov; 32(11):e4347. PubMed ID: 30047564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micellar-based spectrofluorimetric method for the selective determination of ledipasvir in the presence of sofosbuvir: application to dosage forms and human plasma.
    Abdel-Lateef MA; Ali R; Omar MA; Derayea SM
    Luminescence; 2020 Jun; 35(4):486-492. PubMed ID: 31869004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
    Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-MS/MS method for determination of sofosbuvir in human plasma.
    Gandhi BM; Rao AL; Rao JV
    Ann Pharm Fr; 2017 Jul; 75(4):257-266. PubMed ID: 28495020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
    Rezk MR; Basalious EB; Karim IA
    J Pharm Biomed Anal; 2015 Oct; 114():97-104. PubMed ID: 26037157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical technique for determination of tasimelteon in human plasma by LC-MS/MS and its application to pharmacokinetic study in humans.
    Yadlapalli SSR; Karra VK; Kommineni V; Katari NK; Manabolu Surya SB
    Biomed Chromatogr; 2019 Mar; 33(3):e4431. PubMed ID: 30412929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.